Alex Vieira Hedge Fund Short Lululemon $LULU Ahead of Earnings.
stock market LIVE TV reiterates Strong Sell rating sharing this information with professional investors in a full investment lesson including live stock charts.
You can also get this live market calls as a subscriber to the complimentary social live copy trading service by sharing on Facebook and Youtube. Currently, there is not sufficient attendees to Facebook Live, or YouTube Live streaming sessions to get this high profitable overnight trades.
Vieira's Lululemon (LULU) earnings call it is worth $47 million dollars each.
When Alex Vieira Fund enters a position a big move is likely to happen, therefore listen to his opinion and make millions of dollars for free! - Alex Vieira Hedge Funds Invest in Ferrari
Investors have further information on how to profit from Lululemon and other companies listed on NASDAQ and NYSE in the Live technical analysis course.
Instead of investing in Lululemon it is preferable that you do so in the world's best portfolio, companies as Amazon (AMZN), Intuitive Surgical (INTC), Apple (APPL) and so on
According to our algorithm the probability for Lululemon to continue underperforming this quarter is 100% therefore do not invest in Lululemon at grossly overvalued price of $66. Find far better investment opportunities in my free stock picks, the world's best market performers.
Shares of Lululemon Athletica Inc. (LULU) plunged 19% in premarket trade Thursday, as a disappointing fiscal fourth-quarter report and outlook prompted multiple downgrades and price target cuts. The selloff puts the yoga gear seller's stock on track to open at the lowest level since January 2016, and to suffer its biggest one-day percentage loss since December 2008. Analyst Ike Boruchow at Wells Fargo cut his rating to market perform, after being at outperform since January 2016, and cut his stock valuation range to $49 to $50 from $78 to $80. Boruchow said he was particularly surprised by the "significant erosion" anticipated in the ecommerce business. "Slowing sales and moderating [gross margins] puts bull thesis on the mat," Boruchow wrote in a note to clients. Susquehanna analyst Sam Poser downgraded the stock to neutral from positive and slashed his price target to $57 from $82, citing weak sales trends and limited visibility on a recovery.